4Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopie dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol, 2002, 47:198 - 208.
5Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren 's syndrome. J Otolaryngol, 2000, 29:28 -34.
6Zachariae C, Held E, Johansen JD, et al. Effect of a moisturizer on skin susceptibility to NiC12. Acta Derm Venereol, 2003, 83:93.
7Tabata N, OGoshi K, Zhen YX, et al. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology, 2000, 200:308 - 313.
8Marty JP. NMF and cosmetology of cutaneous hydration. Ann Dermatol Venereol, 2002, 129:131 - 136.
9Suarez M, Fulton JE Jr. A novel occ lusive dressing for skin resurfacing. Dermatol Surg, 1998, 24:567 - 570.
10Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dernatol, 1999, 140:264.
